Erratum: Preventing tumor progression to the bone by induced tumor-suppressing MSCs: Erratum

Xun Sun; Kexin Li; Rongrong Zha; Shengzhi Liu; Yao Fan; Di Wu; Misato Hase; Uma K Aryal; Chien-Chi Lin; Bai-Yan Li; Hiroki Yokota

doi:10.7150/thno.77186

Erratum: Preventing tumor progression to the bone by induced tumor-suppressing MSCs: Erratum

Theranostics. 2022 Aug 18;12(14):6155-6156. doi: 10.7150/thno.77186. eCollection 2022.

Authors

Xun Sun^{1

2}, Kexin Li^{1

2}, Rongrong Zha^{1

2}, Shengzhi Liu², Yao Fan^{1

2}, Di Wu^{1

2}, Misato Hase^{2

3}, Uma K Aryal⁴, Chien-Chi Lin^{2

5}, Bai-Yan Li¹, Hiroki Yokota^{1

2

5

6}

Affiliations

¹ Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
² Department of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA.
³ Graduate School of Engineering, Mie University, Mie 514, Japan.
⁴ Department of Comparative Pathobiology, Purdue University, West Lafayette, IN 47907, USA.
⁵ Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
⁶ Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Abstract

[This corrects the article DOI: 10.7150/thno.58779.].

Publication types

Published Erratum